CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Titterton Lewis H jr Director | Purchase | +4,000 | $2.68 | $11K | 860,612 |
| 2024-06-13 | Titterton Lewis H jr Director | Purchase | +405 | $2.70 | $1K | 856,612 |
| 2024-06-11 | Titterton Lewis H jr Director | Purchase | +7,102 | $2.66 | $19K | 856,207 |
| 2024-06-10 | Titterton Lewis H jr Director | Purchase | +330 | $2.60 | $858 | 849,105 |
| 2024-06-07 | Titterton Lewis H jr Director | Purchase | +10,738 | $2.52 | $27K | 848,775 |
| 2024-06-07 | Catelani Michael President, COO, & CFO | Purchase | +6,250 | $2.40 | $15K | 35,211 |
| 2024-06-07 | KUMAR AMIT Chief Executive Officer | Purchase | +25,000 | $2.41 | $60K | 516,925 |
| 2024-04-30 | Catelani Michael President, COO, & CFO | Grant or award | +1,189 | $2.52 | $3K | 28,961 |
| 2024-04-09 | Titterton Lewis H jr Director | Purchase | +15,009 | $3.28 | $49K | 838,037 |
| 2024-03-15 | Baskies Arnold M Director | Purchase | +10,000 | $3.63 | $36K | 110,000 |
| 2024-03-15 | KUMAR AMIT Chief Executive Officer | Purchase | +30,000 | $3.22 | $97K | 491,925 |
| 2024-01-12 | Baskies Arnold M Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-01-12 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-01-12 | Catelani Michael President, COO & CFO | Grant or award · Employee Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2024-01-12 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2024-01-12 | Titterton Lewis H jr Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-10-31 | Catelani Michael President, COO & CFO | Grant or award | +1,117 | $2.69 | $3K | 27,772 |
| 2023-10-10 | Titterton Lewis H jr Director | Option exercise | +16,000 | $2.58 | $41K | 823,028 |
| 2023-10-10 | Titterton Lewis H jr Director | Option exercise · Employee Stock Option | −16,000 | 0 | ||
| 2023-07-31 | KUMAR AMIT Chief Executive Officer | Sale | −11,800 | $3.57 | $42K | 461,925 |
Page 4 of 21 · 404 trades